3 Reasons Why You Should Hold Oracle Stock Despite a 29.5% YTD Drop
π ORCL shares dropped 29.5% YTD amid investor anxiety over heavy capital deployment for AI data centers and increased debt obligations.
π° Total cloud revenues hit $9.9 billion in Q4, with Cloud Infrastructure revenue surging 93% to $5.8 billion.
π Remaining Performance Obligations swelled to $638 billion, up 363% from a year ago, indicating secured future demand.
π Fiscal 2027 guidance shows accelerating growth with total revenue expected to rise 27%-29% and cloud revenue growing 57%-63%.
π΅ The board declared a quarterly cash dividend of $0.50 per share, payable July 24, 2026.
π€ Customer-supplied hardware for major AI contracts now totals $75 billion, reducing the need for independent capital raising.
π Non-GAAP EPS guidance was raised to $8.05 for fiscal 2027, representing 18% growth after adjusting for one-time gains.
𧬠Multicloud AI Database business grew 404% in Q4, marking its fastest-growing offering ever.
π₯ Oracle Health is set to incorporate an AI-driven version of the Cerner patient care management system.
β οΈ The company recorded negative free cash flow of $23.7 billion in fiscal 2026 as capex outpaced operating cash flow.
π Software revenues declined slightly, highlighting the ongoing strategic shift away from legacy licensing models.
ποΈ Oracle plans to raise roughly $40 billion more in debt and equity during fiscal 2027 to fund expansion.
π ORCL is expanding its multicloud footprint by making its database available across Amazon, Microsoft, and Google environments.
π The stock trades at a trailing P/E ratio of 22.64x, which is higher than the sector average but reflects growth expectations.
βοΈ Zacks Investment Research maintains a 'Hold' (Rank #3) rating, advising patience rather than aggressive buying.
- Record demand evidenced by Remaining Performance Obligations swelling to $638 billion, up 363% from the prior year.
- Cloud Infrastructure revenues surged 93% to $5.8 billion in the fourth quarter.
- Accelerating fiscal 2027 guidance with total revenue growth projected between 27% and 29%.
- Raised non-GAAP earnings-per-share guidance to $8.05 for fiscal 2027, representing 18% growth.
- Customer-supplied hardware totaling $75 billion reduces the capital Oracle must independently raise.
- Multicloud AI Database business grew 404% in Q4, described as the fastest-growing offering ever.
- Health application suite integration with Cerner expected to push overall Oracle Health growth into double digits.
- Declaration of a quarterly cash dividend of $0.50 per share signals confidence in underlying cash generation.
- Shares have tumbled roughly 29.5% year-to-date, underperforming the technology sector's appreciation.
- Negative free cash flow of $23.7 billion in fiscal 2026 as capital investment outpaced operating cash flow.
- Plans to raise roughly $40 billion more in debt and equity during fiscal 2027 increase financial leverage.
- Software revenues declined slightly for the year, underscoring the ongoing shift away from legacy licensing.
- Risks include the ability to secure sufficient data center capacity and source graphics processing units.
- Complexity of managing large-scale government and enterprise contracts could affect revenue conversion.
- Stock trades at a premium with a trailing P/E ratio of 22.64x, higher than the sector average.